Mangoceuticals Seeks to Raise Capital with New Share Registration

Rhea-AI Filing Summary

Mangoceuticals has received a Notice of Effectiveness from the SEC for their Form S-3 registration statement, effective as of June 24, 2025, at 4:00 P.M. The Form S-3 (File Number: 333-288039) is a shelf registration statement that allows the company to offer and sell securities to the public.

A Form S-3 filing indicates that Mangoceuticals meets certain eligibility requirements, including being current with SEC reporting obligations. This registration enables the company to access capital markets more efficiently by allowing them to register securities for future public offerings. The effectiveness notice means the company can now proceed with securities offerings under this registration statement.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 24, 2025 4:00 P.M.

Form:

S-3

CIK:	0001938046
Company Name:	MANGOCEUTICALS, INC.
File Number:	333-288039

FAQ

What type of SEC filing did MGRX submit that became effective on June 24, 2025?

MGRX's Form S-3 registration statement (File Number 333-288039) became effective on June 24, 2025 at 4:00 P.M. A Form S-3 is typically used for registering securities for public offerings.

When did Mangoceuticals (MGRX) S-3 filing become effective?

Mangoceuticals' (MGRX) Form S-3 registration statement became effective on June 24, 2025 at 4:00 P.M. Eastern Time, as indicated in the Notice of Effectiveness from the Securities and Exchange Commission.

What is the file number for MGRX's S-3 registration statement?

The file number for Mangoceuticals' (MGRX) S-3 registration statement is 333-288039, as documented in their SEC filing.

What is MGRX's CIK number with the SEC?

Mangoceuticals, Inc. (MGRX) has a CIK number of 0001938046 with the Securities and Exchange Commission, as shown in their registration statement.